Medicaid Discount Classification: Will Trump And Grassley Tag Team Against Pharma?
Confirmation hearing for HHS Nominee Price could give Sen. Grassley chance to get new administration on record prioritizing enforcement against drugs that have been providing smaller than appropriate Medicaid discounts.
You may also be interested in...
CMS Administrator-nominee Seema Verma promises stronger agency oversight of Medicaid drug rebate program in response to question from Sen. Grassley during Senate confirmation hearing.
HHS Secretary nominee suggests there may be better ways to close the Medicare Part D donut hole during his confirmation hearing before the Senate Finance Committee; physician payment transparency, vaccines and HHS price negotiation in Medicare also came up during the session.
$465m settlement with DOJ to resolve questions about EpiPen's classification is roughly the size of autoinjector's Medicaid and Medicare sales last year; Mylan expects to enter corporate integrity agreement.